Seeing Is Believing
Currently out of the existing stock ratings of Frank Takkinen, 153 are a BUY (93.87%), 10 are a HOLD (6.13%).
Analyst Frank Takkinen, currently employed at LAKE STREET, carries an average stock price target met ratio of 41.69% that have a potential upside of 27.75% achieved within 123 days.
Frank Takkinen’s has documented 313 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on HYPR, Hyperfine at 19-Mar-2026.
Analyst best performing recommendations are on COCH (ENVOY MEDICAL).
The best stock recommendation documented was for NOTV (INOTIV) at 5/16/2024. The price target of $2 was fulfilled within 1 day with a profit of $0.14 (6.54%) receiving and performance score of 65.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Nov-2025
$85
$34.87 (69.56%)
$110
27 days ago
(05-Mar-2026)
14/18 (77.78%)
$22.54 (36.09%)
42
Hold Since 22-Jan-2026
$70
$19.87 (39.64%)
$96
1 months 20 days ago
(12-Feb-2026)
22/42 (52.38%)
$10.35 (17.35%)
185
Buy Since 13-Apr-2020
$85
$34.87 (69.56%)
$165
1 months 20 days ago
(12-Feb-2026)
22/30 (73.33%)
$25.35 (42.50%)
203
Buy Since 14-Apr-2023
$85
$34.87 (69.56%)
$130
1 months 20 days ago
(12-Feb-2026)
7/14 (50%)
$25.35 (42.50%)
51
Hold Since 22-Sep-2025
$91
$40.87 (81.53%)
$89
3 months 9 days ago
(23-Dec-2025)
6/11 (54.55%)
$-3.98 (-4.19%)
190
Which stock is Frank Takkinen is most bullish on?
Which stock is Frank Takkinen is most reserved on?
What Year was the first public recommendation made by Frank Takkinen?